Search Legislation

The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020

Changes over time for: Paragraph 7

 Help about opening options

Alternative versions:

Changes to legislation:

There are currently no known outstanding effects for the The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 7. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

This section has no associated Explanatory Memorandum

7.  In regulation 10 (amendment of regulation 8 (general interpretation))—U.K.

(a)in paragraph (2)—

(i)in the definition of—

(aa)“Annex I to the 2001 Directive”, after “means” insert “ , in relation to UKMA(GB), ”;

(bb)“conditional marketing authorisation”, for “UK marketing authorisation” substitute “ UKMA(GB) ”;

(ii)at the appropriate place in the list of definitions to be inserted, insert—

EU agreed paediatric investigation plan” means a paediatric investigation plan agreed in accordance with the Paediatric Regulation;

nursing home” has the meaning given by article 11 of the Health and Personal Social Services (Quality, Improvement and Regulation) (Northern Ireland) Order 2003 M1;; and

parallel import licence” has the meaning given in regulation 48(2);;

“qualifying Northern Ireland goods” has the same meaning that it has in the European Union (Withdrawal) Act 2018, including any meaning defined for the purposes of that Act from time to time by regulations made under the power conferred by section 8C(6) of that Act;;

under the unfettered access route” means an application for—

(a)a UKMA(GB) under reduced or alternative requirements specified in Part 5 (as referred to in regulation 49(1A));

(b)a COR(GB) under reduced or alternative requirements specified in Part 6 (as referred to in regulation 103(1A));

(c)a THR(GB) under reduced or alternative requirements specified in Part 7 (as referred to in regulation 127(1A));;

withdrawal agreement” has the meaning given in section 39 of the European Union (Withdrawal Agreement) Act 2020;;

(b)in paragraph (3)—

(i)before sub-paragraph (a) insert—

(za)in the definition of “advanced therapy medicinal product”, after “means” insert “ , in the case of a medicinal product for sale or supply by the holder of a UKMA(NI) or UKMA(UK), ”;

(zb)in the definition of “certificate of registration”, after “these Regulations” insert—

and—

(a)COR(UK)” means such a certificate in force in the whole United Kingdom;

(b)COR(GB)” means such a certificate in force in Great Britain only;

(c)COR(NI)” means such a certificate in force in Northern Ireland only;;;

(ii)for sub-paragraph (a) substitute—

(a)for the definition of “the Good Manufacturing Practice Directive” substitute—

the Good Manufacturing Practice Directive” means—

(a)in the case of a medicinal product manufactured or assembled in, or imported into, Great Britain—

(i)Commission Directive 2003/94/EC laying down the principles and guidelines of good manufacturing practice for medicinal products for human use and for investigational medicinal products for human use, as modified by Schedule 2A, or

(ii)if Regulations have been made under the powers in regulation B17(1), and have come into force, those Regulations;

(b)in the case of a medicinal product manufactured or assembled in, or imported into, Northern Ireland, Commission Directive 2003/94/EC laying down the principles and guidelines of good manufacturing practice for medicinal products for human use and for investigational medicinal products for human use;;;

(iii)in sub-paragraph (b) (amendment of definition of “homoeopathic medicinal product”) for “substitute “the British Pharmacopoeia”” to the end substitute—

substitute—

(i)in relation to a certificate of registration or marketing authorisation for a national homoeopathic product in force in Great Britain only, the British Pharmacopoeia, or in an pharmacopoeia used officially in an country that is included in a list published by the licensing authority for this purpose;

(ii)in relation to a certificate of registration or marketing authorisation for a national homoeopathic product in force in the whole United Kingdom or in Northern Ireland only, in the British Pharmacopoeia or in any pharmacopoeia used officially in an EEA State;.;

(iv)omit sub-paragraph (d) (amendment of definition of “name”);

(v)in sub-paragraph (e) (amendment of definitions of “pharmacovigilance system”, “pharmacovigilance system master file” and “post-authorisation safety study”) for “for “marketing authorisation, traditional” to the end substitute “for “marketing authorisation” substitute “ UK marketing authorisation, EU marketing authorisation ””;

(vi)for sub-paragraph (j) (amendment of definition of “the summary of the product characteristics”) substitute—

(j)in the definition of “traditional herbal registration”, after “these Regulations” insert—

and—

(a)THR(UK)” means such a registration in force in the whole United Kingdom;

(b)THR(GB)” means such a registration in force in Great Britain only;

(c)THR(NI)” means such a registration in force in Northern Ireland only;;;

(vii)for sub-paragraph (k) (amendment of definition of “UK marketing authorisation”) substitute—

(k)for the definition of “UK marketing authorisation” substitute—

UK marketing authorisation” means a marketing authorisation granted by the licensing authority under Part 5 of these Regulations or Chapter 4 of Title III to the 2001 Directive (mutual recognition and decentralised procedure) and—

(a)UKMA(UK)” means such an authorisation in force in the whole United Kingdom;

(b)UKMA(GB)” means such an authorisation in force in Great Britain only;

(c)UKMA(NI)” means such an authorisation in force in Northern Ireland only.;;

(c)in paragraph (4) omit subparagraphs (i), (ii), (iv), (vii), (viii), (ix), (x), (xi) and (xii);

(d)after paragraph (7) insert—

(8) After paragraph (8) insert—

(9) Unless otherwise provided, any provision of an EU Regulation made applicable to a UKMA(NI), COR(NI) or THR(NI) by virtue of Article 5(4) of, and Annex 2 to, the Protocol on Ireland/Northern Ireland in the EU withdrawal agreement applies equally in respect of a UKMA(UK), COR(UK) or THR(UK)...

Commencement Information

I1Sch. 2 para. 7 in force at 31.12.2020 immediately before IP completion day, see reg. 1

Marginal Citations

Back to top

Options/Help

Print Options

You have chosen to open The Whole Instrument

The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open The Whole Instrument as a PDF

The Whole Instrument you have selected contains over 200 provisions and might take some time to download.

Would you like to continue?

You have chosen to open The Whole Schedule

The Whole Schedule you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open The Whole Schedule as a PDF

The Whole Schedule you have selected contains over 200 provisions and might take some time to download.

Would you like to continue?

You have chosen to open the Whole Instrument

The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources